Losers Recap: New Gold Inc, Chelsea Therapeutics International, InvenSense Inc. (NYSE:INVN), Accuray Incorporated

Lakeway, NY -- (SBWIRE) -- 02/28/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

New Gold Inc. (USA) (NYSE:NGD) declined 3.74% and closed at $8.75 on a traded volume of 2.48 million shares. New Gold Inc. plans to announce its fourth quarter and year end 2012 financial results after market close on February 28, 2013. A webcast and conference call to discuss these results will be held on Friday, March 1, 2013, at 9:00 a.m. Eastern Time.

How Should Investors Trade NGD After The Recent Price movement? Find out Here

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) went down 3.70% and closed at $1.56 on a traded volume of 1.60 million shares. Earlier, the Food and Drug Administration took a more favorable view of a recent study of its drug Northera. Chelsea said that after an appeal, the FDA has decided the company can use the study as the basis for a new request for marketing approval of Northera. The Company said it plans to file for approval during the second quarter and it expects a decision from the FDA before the end of 2013.

Is CHTP a Strong Buying Opportunity After The Recent Slump? Find out Here

InvenSense Inc. (NYSE:INVN) slipped 3.69% and closed at $11.75 on a traded volume of 4.57 million shares. InvenSense, Inc. announced the world's lowest profile and lowest power 3-axis MEMS gyroscope designed for Smartphones, Tablets, Smart TVs, and Gaming devices. The trend toward thinner devices in the consumer electronics market has created demand for components with a maximum height of 0.8mm to allow flexible board placement.

How Should Investors Trade INVN After The Recent Price movement? Find out Here

Accuray Incorporated (NASDAQ:ARAY) went down 3.60% and closed at $4.28 on a traded volume of 1.28 million shares. Accuray Incorporated announced that its management is scheduled to present at the Cowen and Company Annual Healthcare Conference in Boston on Tuesday, March 5, 2013.

How Should Investors Trade ARAY After The Recent Price movement? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.